Archives

by in
Entry Author Date Location
Icahn Aiming for Amylin Sale to Eli Lilly 04/20/09 San Diego
Departed Amylin Co-Founder Greene Says Company in ‘Perfect Storm,’ But Confident in Management 04/13/09 San Diego
Amylin Braces for Proxy Battle Amid Flurry of Filings 04/09/09 San Diego
Phenomix Aims to Grab Piece of $10 Billion Diabetes Market 02/04/09 San Diego
Plot Thickens at Amylin: Eastbourne Capital Enters Power Play With Carl Icahn 02/02/09 San Diego
Carl Icahn Makes Move on Amylin Pharmaceuticals 01/29/09 San Diego
Amylin Fourth-Quarter Byetta Sales Drop, Falling Short of Wall Street Estimates 01/27/09 San Diego
Lilly’s San Diego Biotechnology Center of Silence 12/17/08 San Diego
Biotech Survival Index: Cash Woes Creeping Up on San Diego Life Sciences Companies 11/18/08 San Diego
Amylin Cuts 340 Jobs, One Fourth of Staff, To Cope With Falling Diabetes Drug Demand 11/10/08 San Diego
Aileron Develops New Class of Drugs To Go Where None Could Before 11/07/08 Boston
Amylin, Alkermes Shares Plunge On Possible FDA Delays 11/04/08 San Diego
Amylin Shareholder Floats Idea of Selling Company 11/04/08 San Diego
Amylin Resurrects Obesity Drug, in New Combination with Diabetes Drug Symlin 10/04/08 San Diego
Page 2 of 2 « previous page
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.